1. Home
  2. BPRN vs ALLO Comparison

BPRN vs ALLO Comparison

Compare BPRN & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Princeton Bancorp Inc. (PA)

BPRN

Princeton Bancorp Inc. (PA)

N/A

Current Price

$33.96

Market Cap

220.5M

Sector

Finance

ML Signal

N/A

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.43

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BPRN
ALLO
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.5M
252.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BPRN
ALLO
Price
$33.96
$1.43
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$35.00
$8.67
AVG Volume (30 Days)
8.2K
2.4M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
4.20%
N/A
EPS Growth
62.30
N/A
EPS
2.57
N/A
Revenue
$76,577,000.00
N/A
Revenue This Year
$13.51
N/A
Revenue Next Year
$6.01
$100.00
P/E Ratio
$12.95
N/A
Revenue Growth
13.94
N/A
52 Week Low
$27.25
$0.86
52 Week High
$38.78
$3.78

Technical Indicators

Market Signals
Indicator
BPRN
ALLO
Relative Strength Index (RSI) 56.91 58.50
Support Level $33.41 $1.30
Resistance Level $33.95 $1.52
Average True Range (ATR) 0.71 0.10
MACD -0.01 0.02
Stochastic Oscillator 60.49 70.31

Price Performance

Historical Comparison
BPRN
ALLO

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: